Lombardi Anna, De Luca Mariarosaria, Fabiani Dario, Sabatella Francesco, Del Giudice Carmen, Caputo Adriano, Cante Luigi, Gambardella Michele, Palermi Stefano, Tavarozzi Rita, Russo Vincenzo, D'Andrea Antonello
Department of General Medicine, San Leonardo Hospital, 80053 Castellammare di Stabia, Italy.
Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
J Clin Med. 2023 Jan 29;12(3):1057. doi: 10.3390/jcm12031057.
SARS-CoV-2 (severe acute respiratory syndrome Coronavirus-2) rapidly spread worldwide as COVID-19 (Coronavirus disease 2019), causing a costly and deadly pandemic. Different pulmonary manifestations represent this syndrome's most common clinical manifestations, together with the cardiovascular complications frequently observed in these patients. Ultrasound (US) evaluations of the lungs, heart, and lower limbs may be helpful in the diagnosis, follow-up, and prognosis of patients with COVID-19. Moreover, POCUS (point-of-care ultrasound) protocols are particularly useful for patients admitted to intensive care units. The present review aimed to highlight the clinical conditions during the SARS-CoV-2 pandemic in which the US represents a crucial diagnostic tool.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为2019冠状病毒病(COVID-19)在全球迅速传播,引发了一场代价高昂且致命的大流行。不同的肺部表现是该综合征最常见的临床表现,同时这些患者中也经常观察到心血管并发症。对肺部、心脏和下肢进行超声(US)评估可能有助于COVID-19患者的诊断、随访和预后判断。此外,床旁超声(POCUS)方案对入住重症监护病房的患者尤为有用。本综述旨在强调在SARS-CoV-2大流行期间,超声作为一种关键诊断工具的临床情况。